相关实验视频
Updated: Jun 3, 2025

00:07
A Method to Study de novo Formation of Chromatin Domains
Published on: August 23, 2019
5.4K
在非分裂细胞中,保存的切换到较少的催化活性聚合物抑制复合物.
Rachel McCole1, James Nolan2, David M Reck1
1Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
Cell reports
|January 12, 2025
概括
静态细胞利用较不活跃的聚合物抑制复合物2 (PRC2) 并对PRC2抑制剂有抗性. 在这些单元中准EZH1-PRC2将取代正规的PRC1 (cPRC1),但不会取代H3K27me3标记.
科学领域:
- 表观遗传学和基因调节
- 细胞生物学 细胞生物学
- 发展的分子机制的发展.
背景情况:
- 聚合体抑制复合体2 (PRC2) 对于维持细胞身份至关重要.
- PRC2沉积了H3K27me3,为基因抑制招募了正规的PRC1 (cPRC1).
- 在静止细胞中PRC2和PRC1的作用仍然不完全理解.
研究的目的:
- 在静止细胞中研究Polycomb复合体的组成和功能.
- 评估PRC2抑制剂的疗效和静止细胞中PROTAC介导的降解.
- 了解癌症治疗对癌症治疗的影响.
主要方法:
- 在静止细胞中分析Polycomb复合体.
- 用PRC2抑制剂进行治疗.
- 通过PROTAC介导的EZH1-PRC2.2.的降解.
- 对H3K27me3水平和cPRC1占用率的评估.
主要成果:
- EZH1-PRC2和cPRC1是静止细胞中目标基因上占主导地位的聚合物复合体.
- 静止细胞对PRC2抑制剂表现出耐药性.
- 在静止细胞中,PROTAC介导的EZH1-PRC2降解部分取代了cPRC1,但没有减少H3K27me3.3.
- 在非分裂细胞中发现了一种保存的切换到具有较少催化活性的Polycomb复合体.
结论:
- 不分裂的细胞采用了不同的聚合物复合物的组成和功能.
- 在具有大量静止细胞群的癌症中,PRC2抑制剂可能效果较差.
- 需要进行进一步的研究,以探索针对静止癌细胞中聚合物复合物的治疗策略.
相关概念视频
Heterochromatin
10.4K
The extent of chromatin compaction can be studied by staining chromatin using specific DNA binding dyes. Under the microscope, the dense-compacted regions that take up more dye are called heterochromatin. Heterochromatin is further classified into two forms – constitutive heterochromatin and facultative heterochromatin.
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
10.4K
Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Combinatorial Gene Control
8.3K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K

